Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats New LAL-D

    Launch of LAL-D Knowledge Centre

    A new educational resource on lysosomal acid lipase deficiency is
    now available to epgonline.org users. Content highlights include latest
    disease awareness facts and statistics, important treatment information and
    a video channel comprising expert discussions on topics such
    as diagnostic approach and current prognosis.

  • ,CSU news case studies 2016

    Updates to the Chronic Spontaneous
    Urticaria Knowledge Centre

    Case studies from urticaria experts Professor Christian Vestergaard
    and Professor Torsten Zuberbier have been added to the ‘Case Studies
    section of the Chronic Spontaneous Urticaria Knowledge Centre.
    Additionally, this resource has been updated with information
    on the TARGET My Hives app and refreshed with a whole new look and feel.

  • ,OAC Reversal Whats New 2

    Launch of Oral Anticoagulation Reversal Knowledge Centre

    This new resource provides healthcare professionals with accurate information on the approaches
    to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding,
    or require surgery. View illustrated and referenced sections on management of bleeding, oral
    anticoagulants, symposium highlights, key publications commentary and more. This resource is
    developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with
    content provided by CSL Behring.

    This resource is not intended for healthcare professionals outside Europe.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.


  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

Latest News

Ocular Therapeutix, Inc.receives Complete Response Letter from the FDA relating to Dextenza (dexamethasone insert) 0.4 mg, for intracanalicular use in the treatment of ocular pain post surgery.


Ocular Therapeutix, Inc. a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced that it received a Complete Response Letter (CRL) from the FDA regarding ...

Celegene terminates studies for Revlimid (lenalidomide) for diffuse large B-cell lymphoma following first-line rituximab plus CHOP chemotherapy (R-CHOP) induction therapy.


Celgene Corporation and the Lymphoma Study Association (LYSA) announced that the Lymphoma Academic Research Organisation (LYSARC) reported initial data from a phase III, randomized, double-blind, international clinical study (REMARC). This ...

LUX-Head & Neck 2 and 4 trials discontinued as no advantage evident with Giotrif (afatinib) for treatment of head and neck cancer- Boehringer


Boehringer Ingelheim has decided to stop the global LUX-Head & Neck 2 trial (NCT01345669) as well as its Asian companion trial, LUX-Head & Neck 4 (NCT02131155). Both Phase III trials investigate afatinib in patients with locally advanced head and ...

FDA approves Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) extended-release for GT1 Hepatitis C - Abbvie


The FDA has approved a New Drug Application (NDA) for Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) extended-release tablets, from AbbVie. Viekira XR is a once-daily, extended-release co-formulation of the active ingredients in ...

CHMP recommends Orencia (abatacept) plus methotrexate (MTX) to treat Rheumatoid Arthritis in patients not previously treated with MTX.- BMS


BMS announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion, recommending the approval of Orencia (abatacept) intravenous (IV) infusion and subcutaneous (SC) injection, ...

NICE recommends Lonsurf (trifluridine/tipiracil) treatment for colorectal cancer.- Servier


The National Institute for Health and Care Excellence (NICE) has given draft guidance recommending Lonsurf (trifluridine/tipiracil) from Servier to treat metastatic colorectal cancer in patients previously treated with or who are not candidates for ...

Telotristat etiprate filing is accepted by EMA as a treatment for carcinoid syndrome.- Ipsen


Ipsen announced that the European Medicines Agency (EMA) has accepted the submission of filing for telotristat etiprate as an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in ...

Recent Updates


Clinical Guidelines

2016 European Guidelines on cardiovascular disease prevention in clinical practice

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

EASL Clinical Practice Guidelines on the management of benign liver tumours

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

Medical Journals

Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.

Hypothyroidism and obesity: An intriguing link.

Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.

Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors